Thrombin - Ethicon/OMRIX Biopharmaceuticals

Drug Profile

Thrombin - Ethicon/OMRIX Biopharmaceuticals

Alternative Names: Evithrom; Human plasma-derived thrombin

Latest Information Update: 19 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ethicon; OMRIX Biopharmaceuticals
  • Class Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Serine endopeptidases
  • Mechanism of Action Thrombin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Surgical blood loss

Most Recent Events

  • 15 Oct 2007 Launched for Surgical blood loss in USA (Topical)
  • 27 Aug 2007 Registered for Surgical blood loss in USA (Topical)
  • 06 Nov 2006 Preregistration for Surgical blood loss in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top